Huateng Pharma to Showcase Key Product Lines at CPHI Frankfurt 2025

Frankfurt, Germany – October 28–30, 2025 – Huateng Pharma has announced its participation in CPHI Frankfurt 2025 and will exhibit at Stand 4.1H64. Following its presence at last year’s CPHI Milan, the company aims to reconnect with industry attendees and expand its global partnerships during the three-day event at Messe Frankfurt.

Huateng Pharma will highlight a broad portfolio of products and custom manufacturing capabilities, including:

PEG Derivatives
Monodispersed and polydispersed PEGs with supply ranging from milligram scale to 100 kg, including GMP-grade options.

Pharmaceutical Intermediates
Key intermediates such as those for loxoprofen and voxelotor.

Veterinary APIs
Fluralaner, afoxolaner, atipamezole HCl, and additional veterinary actives.

Cosmetic Ingredients
DHHB, tetrahydrocurcumin, piroctone olamine, and other specialty cosmetic materials.

Specialty & Fine Chemicals

Custom CDMO Services
Project-based synthesis and manufacturing support tailored to client needs.

Attendees are encouraged to visit the booth or arrange a meeting in advance with the on-site team.

Meeting Requests & Media Contact:
Huateng Pharma

sales@huatengusa.com

Sonia Li

Huateng Pharma welcomes the opportunity to meet with partners, researchers, manufacturers, and media representatives during the exhibition.